• OPEN AN ACCOUNT
Indian Indices
Sensex
76,933.59 -539.35
( -0.70%)
Global Indices
Nasdaq
53,487.87 -110.53
(-0.21%)
Dow Jones
7,697.38 -0.90
(-0.01%)
Hang Seng
66,058.92 -203.24
(-0.31%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.31 -0.39
(-0.41%)
EUR-INR
111.19 -0.48
(-0.43%)
GBP-INR
129.97 -0.53
(-0.40%)
JPY-INR
0.60 0.00
(-0.54%)

EQUITY - MARKET SCREENER

Wanbury Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524212
INE107F01022
41.3181644
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WANBURY
15.02
891.31
EPS(TTM)
Face Value()
Div & Yield %
16.97
10
0
 

TACC to collaborate with NUS I-FIM for next-gen advanced materials technologies
Jun 02,2026

TACC, an LNJ Bhilwara Group company and wholly owned subsidiary of HEG, has signed a Memorandum of Understanding (MOU) with the Institute for Functional intelligent Materials (I-FIM) at the National University of Singapore (NUS) to collaborate in the fields of advanced materials science, nanotechnology, and related disciplines.

The collaboration reflects a shared vision between academia and industry to accelerate the development, validation, and commercialization of next-generation advanced materials technologies, including graphene and other functional nanomaterials.

The MoU establishes a framework for long-term cooperation between TACC and NUS I-FIM, combining TACC's industrial and commercialization capabilities with NUS' globally recognized scientific research expertise.